Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
77
AZN Quote, Financials, Valuation and Earnings
Last price:
$202.80
Seasonality move
:
5.44%
Day range:
$198.72 - $201.74
52-week range:
$122.48 - $212.71
Dividend yield:
1.55%
P/E ratio:
62.36x
P/S ratio:
10.86x
P/B ratio:
6.51x
Volume:
2.1M
Avg. volume:
1.9M
1-year change:
38.24%
Market cap:
$317B
Revenue:
$58.9B
EPS (TTM):
$3.28
Analysts' Opinion
-
Consensus RatingAstraZeneca PLC has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $135.50, AstraZeneca PLC has an estimated downside of -56.66% from its current price of $200.73.
-
Price Target UpsideAccording to analysts, the highest upside price target is $184.00 representing -100% upside increase from its current price of $200.73.
Fair Value
-
According to the consensus of 1 analyst, AstraZeneca PLC has -56.66% downside to fair value with a price target of $135.50 per share.
AZN vs. S&P 500
-
Over the past 5 trading days, AstraZeneca PLC has overperformed the S&P 500 by 3.89% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
AstraZeneca PLC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
AstraZeneca PLC has grown year-over-year revenues for 11 quarters straight. In the most recent quarter AstraZeneca PLC reported revenues of $15.5B.
Earnings Growth
-
AstraZeneca PLC has grown year-over-year earnings for 9 quarters straight. In the most recent quarter AstraZeneca PLC reported earnings per share of $0.74.
Enterprise value:
335.1B
EV / Invested capital:
--
Price / LTM sales:
10.86x
EV / EBIT:
24.61x
EV / Revenue:
5.70x
PEG ratio (5yr expected):
1.36x
EV / Free cash flow:
37.33x
Price / Operating cash flow:
71.10x
Enterprise value / EBITDA:
17.31x
Gross Profit (TTM):
$43.7B
Return On Assets:
9.29%
Net Income Margin (TTM):
17.42%
Return On Equity:
23.12%
Return On Invested Capital:
13.53%
Operating Margin:
18.93%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $45.8B | $53.9B | $58.8B | $14.8B | $15.5B | |
| Gross Profit | $33.4B | $39B | $43.7B | $10B | $11.2B | |
| Operating Income | $7.4B | $10.9B | $13.6B | $2B | $2.9B | |
| EBITDA | $12.8B | $17.6B | $19.4B | $4.3B | $4.4B | |
| Diluted EPS | $1.91 | $2.25 | $3.28 | $0.48 | $0.74 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $26.2B | $22.6B | $25.1B | $25.8B | $28.7B | |
| Total Assets | $105.4B | $96.5B | $101.1B | $104B | $114.1B | |
| Current Liabilities | $22.6B | $26.3B | $30.5B | $27.9B | $30.6B | |
| Total Liabilities | $66.1B | $59.4B | $62B | $63.2B | $65.3B | |
| Total Equity | $39.3B | $37.1B | $39.2B | $40.9B | $48.7B | |
| Total Debt | $30.4B | $28.9B | $28.1B | $30B | $29B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $10.6B | $12.2B | $14.9B | $3B | $2.4B | |
| Cash From Investing | -$4.4B | -$8.3B | -$7.1B | -$1.2B | -$1.5B | |
| Cash From Financing | -$6.6B | -$4B | -$7.6B | -$671M | -$3.3B | |
| Free Cash Flow | $6.9B | $7.6B | $9B | $2B | $1.1B | |
AZN
Sector
Market Cap
$317B
$24.3M
Price % of 52-Week High
94.37%
46.97%
Dividend Yield
1.55%
0%
Shareholder Yield
2.07%
-1.86%
1-Year Price Total Return
38.24%
-17.65%
Beta (5-Year)
0.346
0.513
Dividend yield:
1.55%
Annualized payout:
$3.13
Payout ratio:
--
Growth streak:
2 years
Technicals
8-day SMA
Buy
Level
$190.08
200-day SMA
Buy
Level
$171.43
Bollinger Bands (100)
Buy
Level
179.19 - 197.41
Chaikin Money Flow
Buy
Level
258.2M
20-day SMA
Buy
Level
$191.11
Relative Strength Index (RSI14)
Buy
Level
61.09
ADX Line
Buy
Level
22.26
Williams %R
Sell
Level
-5.2196
50-day SMA
Buy
Level
$194.28
MACD (12, 26)
Sell
Level
-0.71
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
371.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.6615)
Buy
CA Score
(Annual)
Level (-0.0857)
Buy
Beneish M-Score
(Annual)
Level (-2.4406)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.6224)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, AZN has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AZN average analyst price target in the past 3 months is $135.50.
-
Where Will AstraZeneca PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that AstraZeneca PLC share price will drop to $135.50 per share over the next 12 months.
-
What Do Analysts Say About AstraZeneca PLC?
Analysts are divided on their view about AstraZeneca PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that AstraZeneca PLC is a Sell and believe this share price will rise from its current level to $87.00.
-
What Is AstraZeneca PLC's Price Target?
The price target for AstraZeneca PLC over the next 1-year time period is forecast to be $135.50 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AZN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for AstraZeneca PLC is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of AZN?
You can purchase shares of AstraZeneca PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase AstraZeneca PLC shares.
-
What Is The AstraZeneca PLC Share Price Today?
AstraZeneca PLC was last trading at $202.80 per share. This represents the most recent stock quote for AstraZeneca PLC. Yesterday, AstraZeneca PLC closed at $200.73 per share.
-
How To Buy AstraZeneca PLC Stock Online?
In order to purchase AstraZeneca PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get AZN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AZN
Sector
P/E ratio
62.36x
21.48x
PEG ratio
1.36x
-0.01x
P/B ratio
6.51x
1.72x
Price / LTM sales
10.86x
1.44x
Growth Metrics
AZN
Sector
Revenue growth
4.93%
3.36%
Earnings growth
56.19%
14.79%
Revenue (5-year growth)
16.37%
6.26%
Earnings forecast
$1.08
-$0.22
Profitability
AZN
Sector
Profitability FY 2025
$43.9B
$2.4M
Return on invested capital
13.53%
-33.32%
Return on assets
9.29%
-29.45%
Return on equity
23.12%
-40.29%
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
Apr
29
Estimated Next Earnings Date
May
12
Balance Sheet
AZN
Sector
Total cash
$5.7B
$25.7M
Short term investments
$37M
$22.7M
Total assets
$114.1B
$70.4M
Long term debt
$29B
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
27
RH alert for Apr 2
RH [RH] is up 0.51% over the past day.
Sell
43
AXTI alert for Apr 2
AXT, Inc. [AXTI] is up 12.33% over the past day.
Buy
72
CAR alert for Apr 2
Avis Budget Group, Inc. [CAR] is up 12.49% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
